FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

Abstract Our aim was to analyse whether biomarkers extracted from baseline 18F-FDG PET before anti-PD1 treatment contribute to prognostic survival information for early risk stratification in metastatic melanoma. Fifty-six patients, without prior systemic treatment, BRAF wild type, explored using 18...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A. Flaus, V. Habouzit, N. De Leiris, J. P. Vuillez, M. T. Leccia, J. L. Perrot, N. Prevot, F. Cachin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/f670e00483354b05be876dfe62c9c6da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares